Clinical Trial Update: Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach [Phase 3]

View source ↗

Summary

Phase 3 intergroup trial evaluating adjuvant chemotherapy for stomach and gastroesophageal junction adenocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Junction Adenocarcinoma
• Stomach Adenocarcinoma

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Adenocarcinoma of the Stomach, Adenocarcinoma of the Gastroesophageal Junction | Phase 3 | Status: COMPLETED